Massimo Conte
Overview
Explore the profile of Massimo Conte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morini M, Barco S, Ardito M, Cafaro A, Pigliasco F, Rossi L, et al.
Oncologist
. 2025 Feb;
30(2).
PMID: 39945419
Background: GD2 ganglioside, a known specific marker for neuroblastoma (NB), exists in different lipoforms, including C18 and C20, which are distinguished by the length of their fatty acid chains. C18...
2.
Amoroso L, Fagioli F, Tondo A, Conte M, Badino C, Di Cataldo A, et al.
Support Care Cancer
. 2025 Feb;
33(3):153.
PMID: 39907793
Purpose: Patients with high-risk neuroblastoma (HR NB) frequently present with metastases in the bone marrow and bone. Approximately 15% of these patients are refractory to induction therapy, and 50% relapse....
3.
Biondi M, Barco S, Cangelosi D, Cafaro A, Morini M, Pigliasco F, et al.
Clin Chim Acta
. 2024 Oct;
565:120005.
PMID: 39419313
Background: Risk assessment at diagnosis is crucial for neuroblastoma (NB) in order to address patients at high-risk to the most timely and appropriate treatments. 3-O-methyldopa (3-OMD), a direct metabolite of...
4.
Palo F, Avanzini S, Barretta I, Monti M, Torre M, Conte M, et al.
Pediatr Surg Int
. 2024 May;
40(1):140.
PMID: 38806812
Purpose: In recent years, the use of robotic-assisted minimally invasive surgery in pediatric oncology has increased. Despite its benefits, its adoption remains limited. This single-center retrospective analysis examines technical nuances,...
5.
Bonfiglio F, Lasorsa V, Aievola V, Cantalupo S, Morini M, Ardito M, et al.
HLA
. 2024 May;
103(5):e15515.
PMID: 38747019
Although a number of susceptibility loci for neuroblastoma (NB) have been identified by genome-wide association studies, it is still unclear whether variants in the HLA region contribute to NB susceptibility....
6.
Ferrari A, Perillo T, Milano G, Silva M, Rutigliano C, Salvo A, et al.
Tumori
. 2024 Apr;
110(4):218-226.
PMID: 38591573
This article describes the oncology programs developed in Italy for adolescents and young adults with cancer, with a specific focus on the local projects created in pediatric oncology centers. A...
7.
Capasso M, Brignole C, Lasorsa V, Bensa V, Cantalupo S, Sebastiani E, et al.
J Transl Med
. 2024 Feb;
22(1):151.
PMID: 38351008
Background: Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Although the overall survival of patients with NB has improved in the last years,...
8.
Fiz F, Cirone A, Righi S, Massollo M, Amoroso L, Bottoni G, et al.
Pediatr Blood Cancer
. 2023 Dec;
71(3):e30806.
PMID: 38082548
Background: I-metaiodobenzylguanidine ( I-mIBG) effectiveness in children with metastasised neuroblastoma (NB) is linked to the effective dose absorbed by the target; a target of 4 Gy whole-body dose threshold has...
9.
Fontana M, Fattori F, Trezzi S, Conte M, Bernardini L, Marando L, et al.
J Migr Health
. 2023 Mar;
7:100177.
PMID: 36968561
Background And Objective: The recent notable increase in refugees' flows, with refugee children and adolescents relocating worldwide, posed severe challenges to the different national healthcare systems. Social groups such as...
10.
Terenziani M, Barretta F, Gattuso G, Bisogno G, Conte M, Crocoli A, et al.
Pediatr Blood Cancer
. 2023 Jan;
70(3):e30200.
PMID: 36625403
This paper retrospectively investigated the site and the detection method of relapses in children and adolescents with malignant germ cell tumors enrolled in the TCGM-AIEOP-2004 Study and subsequently developed a...